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Toxoplasma and Plasmodium are the parasitic agents of toxoplasmosis andmalaria, respectively, and use perforin-
like proteins (PLPs) to invade host organisms and complete their life cycles. The Toxoplasma gondii PLP1 (TgPLP1)
is required for efficient exit from parasitophorous vacuoles in which proliferation occurs. We report structures of
the membrane attack complex/perforin (MACPF) and Apicomplexan PLP C-terminal b-pleated sheet (APCb) do-
mains of TgPLP1. The MACPF domain forms hexameric assemblies, with ring and helix geometries, and the APCb
domain has a novel b-prism fold joined to the MACPF domain by a short linker. Molecular dynamics simulations
suggest that the helical MACPF oligomer preserves a biologically important interface, whereas the APCb domain
binds preferentially through a hydrophobic loop to membrane phosphatidylethanolamine, enhanced by the ad-
ditional presence of inositol phosphate lipids. This mode of membrane binding is supported by site-directed mu-
tagenesis data from a liposome-based assay. Together, these structural and biophysical findings provide insights
into the molecular mechanism of membrane targeting by TgPLP1.ded
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 INTRODUCTION
Up to one-third of the global population is thought to be infected
with Toxoplasma gondii, a zoonotic agent of disease that can be fatal
in developing fetuses and the immunocompromised (1, 2). Infection
commonly manifests in fever, headache, myalgia, and anorexia (3).
Chronic infection by Toxoplasma is believed to underlie forms of psy-
chiatric pathology (4, 5).T. gondiihas a heteroxenous life cycle inwhich
an obligate sexual feline stage of parasitism is coupled to asexual re-
production in a nonfeline host (2, 3, 5, 6). The cell forms associated
with asexual proliferation of parasites include primarily the tachyzoite,
but others are cyst-forming bradyzoites and merozoites that expand
the parasite load in the cat intestine. Tachyzoites invade and repro-
duce within host cells by the formation of a parasitophorous vacuole
(PV) from host cell membranes within which they can grow in a
protected environment. Escape from the PV, and therefore from the
infected cell, for subsequent rounds of infection has been shown to be
dependent on the perforin-like protein TgPLP1 (T. gondii PLP) (7–9).
So far, little information has been available concerning the struc-
ture and mechanism of TgPLP1. Within T. gondii genome sequences,
the ratio of nonsynonymous/synonymous single-nucleotide poly-
morphisms (SNPs) for TgPLP1 is 0.1 (24 of 233 SNPs, 64 genomes),
indicating that it is one of the better-conserved Toxoplasma proteins
(http://toxodb.org/toxo/). Sequence analysis reveals that apicomplexan
perforin-like proteins (ApiPLPs) generally have a conserved core
membrane attack complex/perforin (MACPF) domain followed by a
C-terminal b-strand–rich domain [CTD; dubbed Apicomplexan PLP
C-terminal b-pleated sheet (APCb)] and complementedbyN-terminal
domains (NTDs) (fig. S1), which vary greatly in length and may have
significant regions of intrinsic disorder (10).
The MACPF domains of the apicomplexan PLPs are typical of
members of the perforin branch of theMACPF/cholesterol-dependentcytolysin (MACPF/CDC) superfamily of pore-forming andmembrane-
targeting proteins (10, 11). The core feature of the characteristicMACPF/
CDC domain is a bent four-stranded antiparallel b sheet with a set of a
helices suspended between each pair of strands. In all pore-forming
MACPF/CDC proteins characterized to date, oligomerization leads to
conversion of these a helices to form a b sheet [made of transmembrane
hairpins (TMHs)] that continues the domain core (12–14). The recently
solved structure of human astrotactin-2, a protein involved in cell migra-
tion andpolarity, revealed a perforin-like proteinwithmismatchedTMH
regions, suggesting that it is unlikely to be involved in pore formation in
the way that homologous proteins are (fig. S1C) (11, 15). By contrast,
sequence analysis reveals that TgPLP1 and the other apicomplexan PLPs
have TMH regions that would be expected to play a role in membrane
insertion during pore formation or another type of membrane-targeting
mechanism.
Compared with known features of TgPLP1 MACPF domains, the
structure and function of the APCb domain of TgPLP1 are less well
characterized. It is representative of a homologous domain possessed
by all ApiPLPs but has an unknown structure (10). Similar to theCTDs
of perforin itself (a C2 domain) and of the CDCs [immunoglobulin
(Ig)–like domains], which are structurally homologous to each other
(16), it is predicted to be b-sheeted, although built from three copies
of a common motif. Both the NTDs and CTDs (APCb domain) of
TgPLP1 have been reported to have a role in membrane binding
before pore formation, with the APCb domain playing the primary
and essential role (8). Here, we report the structures of the MACPF
domain and APCb domain of TgPLP1, alone and in tandem, and of
two different MACPF domain oligomers. Combined with functional
data, molecular dynamics (MD) simulations, andmutational analysis,
these structural studies provide insights into the molecular mechanism
of TgPLP1 membrane activity.RESULTS
Crystal structures of TgPLP1 MACPF domain
We found that the transient expression ofTgPLP1 inmammalian cells
(17) yields ample protein for structural and biophysical studies (see
Materials and Methods). We first obtained oligomeric crystal forms1 of 12
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 of the TgPLP1MACPF domain by the use of in situ trypsinization in
crystallization drops. On solution of the resulting structures, we
found two related assemblies: a ring-shaped hexamer and a helical
packing arrangement with six subunits per turn. The helical subunit
arrangement was formed in a crystal of space group P65 that dif-
fracted to 2.03 Å with phasing using anomalous scattering from a
single platinum derivative (see Materials and Methods). The ring-
shaped assembly was, by contrast, found in a C2221 crystal form that
diffracted to only 5.0 Å and that we phased by molecular replace-
ment using a single subunit from the P65 crystal form. Molecular
replacement in the same way was also used to solve the structure of
an intact monomeric form of the MACPF domain at 3.11 Å in space
group C2.
For clarity, we describe features of the isolated intact MACPF do-
main first. In addition to the core-bent b sheet, we were able to resolve
the whole of the TMH1 region (helicesa1 anda2) and two parts of the
TMH2 region (helices a7 and a8) (Fig. 1A), although the TMH2
region was partly disordered and thus not visible in the crystal struc-
ture. Whereas TMH1 is packed into a pocket, TMH2 is more exposed
to solvent, explaining itsmobility. In addition to a further set of helices
that cap the top of the core b sheet, we noted two helical inserts (a4
and a5) not present in other MACPF domains to have had their
structures resolved and that a9 is angled out from the core of the do-
main (Fig. 1A). Together, these features cause the TgPLP1 MACPF
domain to be somewhat bulkier than other perforin-like proteins,
which partly explains its capacity to form much smaller oligomers
than other family members (see below).
The helical oligomeric form displays excellent geometry in which
the central b-strands fromadjacent subunits form a continuous b sheet
with six hydrogen bonds between each strand (Fig. 1B and fig. S2A).
Critically, the helical assembly can only form crystallographically with
the trypsinization of TMH2, strongly suggesting that this is an oligo-
meric form related to that generated following membrane attack by
TgPLP1, because cutting away the helical TMH2 will mimic its
transition to a b-stranded form (13, 14, 18). Biologically, no cleavage
would occur, but the TMH2 region would move by spontaneous con-
version to a membrane-inserted set of b-strands as part of TgPLP1
activity.
The orientation of the subunits, with the TMH regions facing
inward, is exactly what would be expected for the biological, and
usually pore-forming, oligomer formed by MACPF/CDC proteins
(13, 14, 18). In addition to the presence of a4 and a5 and the angle of
a9, the subunits of TgPLP1 are tilted sideways to allow closure around
a narrow lumen with six subunits per turn (the smallest previously
describedMACPF/CDColigomer is a dodecamer) (fig. S3) (12). Anal-
ysis with the software HOLE (19) indicates a minimum functional
pore radius for the oligomeric state captured in the helix of 12.45 Å
(fig. S3). We discuss the functional implications of this structure be-
low, but this is the first crystal structure of a MACPF/CDC homo-
oligomer in what is likely to reflect a membrane-active, and possibly
pore-forming, state. By contrast, however, the ring-form oligomer
crystal structure is imperfect with three main-chain hydrogen bonds
being found between only two of the subunit interfaces (“A-B” and
“D-E”). Together with the low resolution of the structure, which was
only subject to rigid-body refinement, this suggests that the ring-form
crystal structure may not represent a functional biological assembly
although it may represent an assembly intermediate. The minimum
functional pore radius for the hexameric ring, estimated as above, is
7.81 Å (Fig. 1C and fig. S3).Ni et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018Anumber of pore-forming proteins have been shown to form their
functional states in solution when concentrated or in the presence
of detergent (20, 21). For example, CDC pneumolysin forms helical
oligomers in solution that preserve the subunit interface and confor-
mation found in the planar ring–shaped pore (14, 18). In line with
this, the treatment of intact TgPLP1 MACPF domains with the de-
tergent deoxycholate results in their oligomerization (Fig. 2 and fig.
S2B), and these oligomerized assemblies are capable of mediating
transmembrane conductance (fig. S2C) when formed from full-length
TgPLP1. Conductancemeasurements of preformedTgPLP1 oligomers
in membranes show the formation of pores of variable size and sta-
bility and, eventually, membrane breakage (fig. S2C); these effects
could be driven by a helical packing of TgPLP1 subunits, which would
be more likely to tear the membrane structure than a planar ring as-
sembly (fig. S2C). However, we do not know the exact oligomeric form
giving rise to pore formation and membrane breakage.
MD simulations of MACPF domain oligomers
To investigate the functional significance of the MACPF domain
oligomers further, we performed MD simulations of both the helical
and ring-form crystal structures (fig. S4). Of most interest was the
resilience of the different subunit interfaces observed. In the crystal
structures, all subunit interfaces in the helical assembly are identical,
but the ring oligomer has three different interfaces, with three, one,
and no main-chain hydrogen bonds, respectively, in contrast to the
six in each of the helical subunit interfaces. The hydrogen bonds ob-
served in the helical assembly are in a different register to those
found in the ring assembly. Over the course of a 100-ns simulation,
the helical interfaces remained intact, whereas the interfaces for the
ring underwent significant variation (figs. S5 and S6). To investigate
whether the interfaces displayed more freedom when isolated from
the oligomer as a whole, we then repeated the simulations but for
dimers extracted from the complete assemblies (fig. S7), producing
similar results to those observed for the simulations of the whole
hexamer. Again, the ring interfaces underwent considerable changes,
whereas the helical interface was maintained. The subunit interface
captured in the helical oligomer could occur in a membrane-bound
ring of six subunits, although in solution, it has relaxed into a helical
arrangement. The ring assembly we observe in the low-resolution
crystal form could be an intermediate on the way to the formation
of such a helix, but its poor geometry and instability make it a poor
candidate for a biologically active structure. It is also possible that
TgPLP1 assemblies of less than six subunits could be active on mem-
branes; the functional significance of incomplete pore-forming rings
ofMACPF/CDC protein subunits is well attested (22–25). In all, these
analyses suggest that the interfaces found in the helical assembly are
more stable and of biological significance, although the resulting func-
tional oligomer remains to be determined.
Crystal structure of TgPLP1 APCb domain
An expression construct representing the TgPLP1 APCb (residues
810 to 1072) was crystallized in space group C2 with the crystals dif-
fracting to 1.1 Å resolution. Its structure (Fig. 3A and fig. S8, A and B)
revealed the arrangement of three homologous repeats in a b-prism
around a tightly packed and extremely hydrophobic (and aromatic)
core. Comparison of the repeats with one another indicates a root
mean square deviation (RMSD) of 1.28 to 1.56 Å over their roughly
80 residues each arranged into six b-strands with four forming one
face of a sandwich and two the other (Fig. 3B). The two sides of the2 of 12
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 Fig. 1. Crystal structure of TgPLP1 MACPF domain. (A) Overall structure of TgPLP1 MACPF domain. Left: The a helices are labeled from a1 to a9 from N to C terminus
of the MACPF domain, the TMHs (a1 to a2 and a7 to a8) are highlighted in red, and the additional a helices (a4 to a5) compared with perforin-1 MACPF domain are
colored in blue. Right: Side views of TgPLP1 MACPF domain showing the angled a9 and the surface charge distribution. (B) Helical assembly of the TgPLP1 MACPF
domain. Top and side views of helical assembly of MACPF domain are shown, with two protein surfaces presented in red and blue. (C) Ring assembly of TgPLP1 MACPF
domain. Top and side views of ring assembly of MACPF domain are shown, with two protein surfaces presented in red and green. The relative positions of proteins in
the helical and ring assemblies are compared, and the diameter of the helix and ring are shown.Ni et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018 3 of 12
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 4 + 2 sandwich forming each repeat are linked together by two high-
ly conserved disulfide bonds, which can be treated as a signature
motif of this domain (26). Comparison of the sequences of all avail-
able apicomplexan PLPs shows that sequences in the inner plane
(four b-strands) facing toward the core are more conserved than in
the outer set (two b-strands) (fig. S8C). Among the other notable
features of theTgPLP1 APCb is the presence of a long projecting loop
at its base, which is tipped by a tryptophan and has additional se-
quence features that make it resemble the similar loops found at the
base of the CTDs of perforin itself and the CDCs (Fig. 3C) (16). How-
ever, the topology of each repeat in the b-prism is different from those
of the perforin andCDCCTDs (which are similar to one another), and
therefore, this common feature in TgPLP1 appears to be a product of
convergent and not divergent evolution (fig. S8D).
MD simulations of TgPLP1 APCb domain interacting
with membrane
To explore in detail the approach made by APCb domains to mem-
branes, we performed both coarse-grained and atomistic MD simula-
tions (Fig. 4 and fig. S9). On the basis of comparison to otherMACPF/
CDCproteins withCTDs, we hypothesized that this would involve the
surface of the domain containing the long loop tipped with a trypto-
phan approaching the membrane first. We found that in membranes
composed of palmitoyloleoylphosphatidylethanolamine (POPE),
palmitoyloleoylphosphatidylcholine (POPC), and palmitoyloleoyl-
phosphatidylserine (POPS) lipids alone in various combinations, this
was the case; however, also in the presence of phosphatidylinositol
4,5-bisphosphate (PIP2) or phosphatidylinositol 3,4,5-trisphosphate
(PIP3), the domain bound upside-down about half the time (fig. S9,
A and B) and associated with the membrane further from its surface.
In the full-length protein, this upside-down binding mode is very
unlikely because of the presence of the MACPF domain, which is
only 11 residues before the first residue of the APCb structure. This
artifactual orientation in the MD simulation is an effect of the extra
charge density associated with the presence of PIP lipids. Atomistic
MD simulations were in agreement with the coarse-grained results
and showed a definite preference for POPE enhanced by PIP2 (Fig.
4C and fig. S9C), whereas the tryptophan-tipped loop inserted intoNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018the hydrophobic core of the bilayer that helps to anchor the domain
in the membrane.
To determine whether the orientation with the long loop down
toward the membrane gives the correct interface for membrane
binding, we used site-directed mutagenesis combined with liposome
sedimentation assays (Fig. 4D). Complementary to our findings from
MD simulations, we found that the wild-type protein had a preference
for POPE and also for PIP3-containingmembranes, but that binding is
reduced by mutation of the extended tip (MLWL→AAAA), by mu-
tation of positively charged residues to neutral ones on the bottom of
the domain (K→A, R→A), and by mutation of a histidine in the loop
to alanine. The MLWL→AAAA and Lys/Arg→Ala mutants had a
greater effect on binding than the His→Ala mutation did, which in-
dicates the primacy of charge-based and hydrophobic interactions for
stable membrane association. Finally, we imaged the APCb domain
binding to the surface of POPE-containing giant unilamellar vesicles
(GUVs) (Fig. 4E).
The structure of the MACPF-APCb tandem domains of TgPLP1
together was studied using small-angle x-ray scattering (SAXS) with
modeling of the resulting data assisted by the shortness of the linker
joining the MACPF and APCb domains (fig. S10). The data indicate
that the likely solution state of the MACPF-APCb tandem is clustered
in two conformations, in neither of which is there formed a close
interface between the two domains.DISCUSSION
We have provided the first crystal structures for an ApiPLP, TgPLP1.
Crystal structures of theMACPFdomain in oligomeric andmonomer-
ic states reveal the formation of a helical hexameric assembly that has a
continuous intersubunit b sheet, and MD simulations and biophysical
characterization suggest that the stable interface within the helical
assembly is more likely to be of biological significance. The crystal
structure of the C-terminal APCb domain reveals a novel b-prism fold
for the signature domain of the ApiPLPs. Together with MD calcula-
tions, site-directed mutagenesis, and fluorescent imaging, our data in-
dicate that the membrane binding of APCb depends on a projecting
hydrophobic loop and positively charged residues surrounding it.Fig. 2. TgPLP1 forms a detergent-induced oligomer. (A) SDS–polyacrylamide gel electrophoresis (SDS-PAGE) of TgPLP1 MACPF-APCb and MACPF domain with or
without detergent. (B) Analytical ultracentrifugation of TgPLP1 MACPF-APCb (0.5 mg/ml) in detergent. The species corresponding to monomer, dimer, and other
oligomers are indicated with arrows.4 of 12
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 Our structural insights are of value for an understanding of the
mechanisms used by ApiPLPs to facilitate parasite invasion and hu-
man disease and set the scene for further studies in which their role
in the life cycles of their respective producing organisms will come to
be further defined. Thework presentedhere demonstrates thatTgPLP1
functions in a way different from any other perforin-like protein so far
described. The existing data on TgPLP1 oligomerization leave open
questions concerning the details of its mechanism of action. For
now, different possibilities exist, which include subunits assembling
in a helical arrangement to disrupt membranes directly, rings or arcs
of subunits forming on membranes, or another kind of functional
assembly. Although our data strongly support a biological role for
the interface captured in the helical oligomer, this will require furtherNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018verification. Our data show that TgPLP1 does not form large ring-
like oligomers onmembranes like otherMACPF/CDCpore-forming
proteins, but rather smaller assemblies. It suggests that the role of
TgPLP1 is not to directly generate a large and stable opening through
the PV membrane, such as those formed by MACPF/CDC proteins
like perforin-1 or the CDCs, but is either to weaken the membrane for
mechanical disruption by parasites or to allow the delivery of small
effector molecules from the PV itself into the cytoplasm or vice versa.
The active state could be a complete helical turn or ring of subunits, or
perhaps more likely a smaller, arc-shaped assembly (23–25). Arcs of
TgPLP1 subunits could function in isolation or together, in which
case they could create patchwork assemblies such as those formed
by the larger arcs of CDC listeriolysin subunits (25, 27). In any case,Fig. 3. Crystal structure of TgPLP1 APCb domain. (A) Overall structure of APCb domain with each repeat colored differently. Left: Side view of APCb domain
highlighting the hydrophobic tip at the bottom. Right: Top view showing threefold pseudosymmetry with four antiparallel b-strands forming the core of the domain.
(B) Superposition of three tandem repeats showing the conservation within the main scaffold and variation in the bottom loop of each repeat. (C) Crystal structure of
pneumolysin and intermedilysin Ig-like domains, with the tryptophan hydrophobic tip highlighted.5 of 12
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 our work establishes the molecular basis for an understanding of the
mechanism of action of a class of MACPF/CDC proteins critical in
some of the world’s most pernicious and debilitating diseases caused
by apicomplexan parasites.MATERIALS AND METHODS
Construct cloning and site-directed mutagenesis
TgPLP1 MACPF domain (residues 462 to 809, N720Q/N744Q) was
cloned into the mammalian protein expression vector pHLsec by in-
serting the DNA fragment between Age I and Kpn I restriction sites,
resulting in a signal peptide in the N terminus of the proteins and aNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018KTHHHHH tag at the C terminus of the protein. The signal peptide
was cleaved during protein secretion into the media, leaving an addi-
tional three residues Glu-Thr-Gly at the N terminus of the proteins.
The APCb domain (residues 810 to 1072) and the MACPF-APCb
domain tandem (residues 462 to 1072) constructs were cloned in
the same way. For site-directedmutagenesis, overlapping polymerase
chain reaction was performed.
Protein expression, purification, and crystallization
All the TgPLP1 proteins used in this study were expressed in mam-
malian human embryonic kidney (HEK) 293T cells according to ex-
pression protocols previously reported (17). The protein expressionFig. 4. Characterization of TgPLP1 APCb membrane binding using MD simulations and liposome sedimentation assays. (A) A snapshot from a 100-ns all-atom
(AT) MD simulation of TgPLP1 APCb domain binding to a lipid bilayer containing 45% POPC, 42% POPE, 10% POPS, 3% PIP2 showing the upright membrane-binding
orientation with the extended loop inserted into the bilayer. Lipids are shown with carbon and oxygen colored in white, nitrogen in blue, phosphate in orange, and PIP2
head groups in red. (B) Density map showing APCb membrane binding to a POPC/POPE/POPS/PIP3 membrane calculated from 20 coarse-grained simulations of 1 ms in
length. The YY component of the rotational matrix of APCb is shown versus the center of mass distance between APCb and the lipid bilayer, indicating two inverse
binding orientations of the domain. (C) Normalized average number of contacts between residues of the APCb residues and each lipid type in the simulation, taken
from three 100-ns AT simulations of APCb with the POPC/POPE/POPS/PIP2 membrane. (D) Liposome sedimentation assay showing that the TgPLP1 APCb domain binds
to membranes and mutations in the hydrophobic tryptophan tip and charge neutralization abolish membrane binding. Mutant 1 (mut1) affects the tryptophan loop tip
(1054MLWL1057-AAAA); mut2 gives charge neutralization (R851A K995A R996A R1030A K1048A); mut3 affects an exposed histidine (H1052A). (E) Fluorescent images of
GUVs labeled with rhodamine-phosphatidylethanolamine (red) interacting with His6-tagged APCb labeled with green fluorescent anti-His6 antibody. Scale bar, 10 mm.
WT, wild type.6 of 12
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 screen was initially carried out in Escherichia coli with its respective
expression vectors (pOPINE, pOPINF, pOPINM, and pOPINJ), re-
sulting in an insoluble aggregate preventing further biophysical
characterization, even after the extensive optimization of expression
tags and purification conditions.
To express the TgPLP1 constructs in HEK293T cells, 6 mg of puri-
fiedDNAwas transfected into 12 roller bottles of HEK293T cells in the
presence of the glycosylation inhibitor kifunensine (final concentration
of 5 mM) with 12 mg of polyethylenimine. The transfected cells were
harvested 4 to 5 days after transfection. Cell media (3 liters) containing
the secreted proteins were harvested by centrifugation at 5000g for
45 min to remove the cell debris, filtered through a 0.22-mm mem-
brane, and dialyzed against a 10× volume of phosphate-buffered saline
[10mMphosphate (pH 7.5) and 300mMNaCl] overnight at 4°C. The
dialyzedmedia were supplemented with 20mM imidazole and loaded
onto a HisTrap HP (GE Healthcare) column overnight at room tem-
perature before elutionwith a linear imidazole gradient (20 to 500mM
imidazole) in 25 mM tris (pH 7.5) and 500mMNaCl. The eluted pro-
teinswere pooled together and deglycosylatedwith Endo_F1 overnight
at 4°C, concentrated, and applied to a size-exclusion chromatography
column (Superdex 200 16/600). The eluted peak corresponding to a
monomeric species was concentrated to about 30 mg/ml in 10 mM
Hepes (pH 7.5) and 150 mM NaCl. The proteins were flash-frozen
in liquid nitrogen and stored at −80°C until further use.
Crystallization screening was carried out using sitting-drop vapor-
diffusion methods in CrystalQuick 96-well plates by mixing 100 nl
of protein solution with 100 nl of reservoir and equilibrated against
95 ml of reservoir. Initial screening for crystals of the intact TgPLP1
MACPF domain at 30 mg/ml resulted in thin plate-like crystals in
100 mM sodium citrate tribasic dehydrate (pH 5.5) and 22% PEG-
1000 (polyethylene glycol, molecular weight 1000) and diffracted to
3.4 Å resolution despite several rounds of attempted optimization.
For trypsin in situ limited proteolysis, a mixture of TgPLP1MACPF
domain (8 mg, 40 mg/ml) and trypsin (5 mg, 1 mg/ml; Prote-ACE,
Hampton) was incubated on ice and rescreened against theHampton
crystallization conditions. The crystals appeared in 0.1MHepes (pH7.5),
10% isopropanol, and 20% PEG-400 conditions and grew to full size
(50 mm × 50 mm × 75 mm) in 3 days. These hexagonal crystals were
used for experimental phasing using K2PtCl4. A second crystal form
of the trypsinized sample had space group C2 in 0.1 MHepes (pH 7.5),
10% alcohol mixture, 15% PEG-1000, 15% PEG-3350, and 15% MPD.
See Table 1 for data collection and crystallographic statistics.
The glycosylated and nonglycosylated forms of TgPLP1 APCb do-
main were eluted at different concentrations of imidazole. The non-
glycosylated form was concentrated to 21 mg/ml and crystallized in
25% PEG-3350, 0.2MMgCl2, and 0.1M bis-tris (pH 5.5). See Table 2
for data collection and crystallographic statistics.
Crystal diffraction data collection, processing, and
structure determination
All the crystals were cryocooled in liquid nitrogen with 25% glycerol as
the cryoprotectant. The crystal diffraction datawere collected on I04 and
I24 beamlines at Diamond Light Source. To experimentally phase the
MACPF domain and APCb domain, crystals were both soaked in con-
centrated K2PtCl6 for 1 hour at room temperature, and the derivative
data sets were collected at a wavelength of 1.0722 Å. All the diffraction
data were indexed, integrated, and scaled using the Xia2 pipeline (28).
Experimental phasing using Pt-derivative data sets was carried out
using HKL2Map (29). For the MACPF domain, crystals soaked withNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018Pt diffracted to 2.3 Å and showed a strong anomalous signal, which
was used to phase the structure using single-wavelength anomalous
dispersion. Electron density for the Pt-derivative data set had a corre-
lation of local RMS density of 0.84 and allowed side chains to be as-
signed without ambiguity. Phase extension to 2.0 Å from the native
data set allowed phenix.autobuild (30) to trace the structure, giving
a model 80% complete. The model was completed manually in Coot
(31) and then refined in phenix.refine (32). The refinedmodel was then
used for the molecular replacement solution of other crystal forms in
phenix.phaser (33). Additional density was immediately identified for
the intact MACPF domain crystals despite their resolution, and to fa-
cilitatemodel building,multiple–data set averaging with noncrystallo-
graphic symmetry was used, resulting in clarified electron density to
which missing residues could be assigned. The intact MACPF crystal
data setwas achieved by combining 10 different sweeps from10 crystals.
See Table 1 for MACPF domain structure determination and refine-
ment statistics.
For the APCb domain, the experimental phasing by platinum de-
rivative single anomalous dispersion at 1.5 Å in phenix.autosol (34)
resulted in an excellent electron densitymapwith unambiguous den-
sity for side chains. This map was used in phenix.autobuild (30) to
automatically generate a partial model. The partial model was then
taken to perform molecular replacement to solve the native data set
structure. The subsequent refinement was performed inCoot (31) and
phenix.refine (32). See Table 2 for APCb domain data collection and
structure refinement statistics.
Detergent-induced oligomerization
TgPLP1 MACPF domain and MACPF-APCb protein were diluted in
20 mM Hepes (pH 7.5), 150 mM NaCl, and 0.1% deoxycholate to a
final concentration of 0.1 mg/ml and incubated at 37°C overnight. For
SDS-PAGE analysis, 10 ml of protein samples was mixed with 5 ml of
SDS-PAGE loading dye and loaded to 3 to 8% SDS-PAGE gradient
gel. For analytical ultracentrifugation, the proteins were diluted in
the same buffer to a final concentration of 0.5 mg/ml.
Analytical ultracentrifugation
Sedimentation velocity experiments were performed using a Beckman
Optima XL-I analytical ultracentrifuge equipped with both absorb-
ance and interference optics. Double-sector 12-mm path-length cen-
terpieces were used with protein samples at 0.5mg/ml and 3-mmpath
lengthwith samples at 1mg/ml, with absorbancemeasurementsmade
at 280 nm. Experiments were performed at 20°C, taking sample distri-
bution scans every 6 min. Data were analyzed using SEDFIT software
using the c(s,f/f0) method of interpretation to generate sample distri-
butions in s (sedimentation coefficient) without assuming a particular
number of species. The resulting distributions were curve-fit in ProFit
(QuantumSoft).
Atomistic MD simulations
All MD simulations were performed using Gromacs v5.1 (35, 36). An
SPCwater model was used. Bond lengths and angles were constrained
using the LINCS algorithm (37). A time step of 0.002 ps was used,
writing atomic coordinates every 10 ps. Temperature was maintained
at 310 K using velocity rescaling, with a coupling constant of 1 ps (38).
In simulations containing lipids, the solvent, protein, and lipid were
separately coupled to an external water bath. Isotropic pressure cou-
pling was used to set the pressure to 1 bar using the Parrinello-Rahman
barostat (39), with a coupling constant of 1 ps. Coulombic forces7 of 12
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 were treated using Particle-Mesh Ewald electrostatics (40). Van
der Waals and electrostatics were shifted to zero at the cutoff of
1 nm.
Proteins were solvated and NaCl ions were added to neutralize the
system and create a salt concentration of 0.1M. Systemswere subjected
to up to 5000 steps of energy minimization using the steepest descent
algorithm. The systemwas equilibrated by restraining positions of pro-
tein heavy atoms using a force constant of 1000 kJmol−1 nm−3 for 1 ns.
The position restraints were then removed, and final production runs
of 100 ns were performed. Three repeats were produced for each
simulation, each starting with random velocities.
MODELLER (41) was used to connect free termini of TgPLP1
MACPF domain. Simulations were prepared using the Amber
99SB-ILDN force field (42).Ni et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018Simulations of TgPLP1 APC-ß domain membrane binding were
performed using theGromos 53a6 force field (43). For atomistic simu-
lations ofTgPLP1APCb bound to amembrane bilayer, coarse-grained
simulations provided an initial configuration of APCb membrane
binding, which was then converted to an atomistic structure for fur-
ther simulations and analysis in greater detail following the conversion
protocol set out by Stansfeld and Sansom (44).
Coarse-grained MD simulations
For coarse-grained simulations, the Martini v2.2 coarse grain force
field was used (45, 46). Lennard-Jones interactions were shifted to zero
between 0.9 and 1.1 nm. The electrostatic potential energy was shifted
to zero between 0 and 1.1 nm. The system was kept at a constant tem-
perature of 323 K coupled using velocity rescaling (38), with protein,Table 1. Data collection and refinement statistics for TgPLP1 MACPF domain.Native_1 (trypsin) Pt derivative (trypsin) Native_2 (trypsin) Native_3 (intact)Data collectionSpace group P65 P65 C2 C2221Cell dimensionsa, b, c (Å) 104.86, 104.86, 52.01 105.53, 105.53, 52.72 159.49, 185.74, 104.19 95.23, 206.58, 82.74a, b, g (°) 90, 90, 90 90, 90, 90 90, 121.48, 90 90, 90, 90Resolution (Å) 90.81–2.03 (2.08–2.03) 52.76–2.34 (2.40–2.34) 56.35–5.11 (5.29–5.11) 64.58–3.11 (3.16–3.11)Rmerge 0.171 (1.994) 0.115 (1.901) 0.131 (1.044) 0.278 (2.132)Rpim 0.041 (0.464) 0.021 (0.341) 0.056 (0.473) 0.049 (0.596)I/sI 13.4 (1.6) 24.0 (2.1) 8.2 (1.5) 12.9 (1.1)Completeness (%) 100 (20.1) 99.3 (93.2) 99.7 (100) 100 (100)Redundancy 13.4 (1.6) 39.6 (31.3) 6.7 (6.7) 31.9 (13.4)CC half 0.999 (0.514) 1.000 (0.444) 0.995 (0.702) 0.997 (0.582)RefinementResolution (Å) 98.37–2.03 (2.08–2.03) 56.35–5.11 (5.29–5.11) 64.58–3.11 (3.16–3.11)No. of reflections 418,830 (42,406) 70,739 (7,144) 482,085 (20,145)Unique reflections 21,264 (2,104) 10,514 (1,060) 15,081 (1,489)Rwork/Rfree 19.11/23.25 28.60/29.73 23.26/26.46No. of atomsProtein 2,144 12,864 4,552Ligand/ion 14 84 22B-factorsProtein 55.34 330.77 101.61Ligand/ion 51.27 363.24 143.68RMSDsBond lengths (Å) 0.002 0.003 0.003Bond angles (°) 0.58 0.65 0.728 of 12
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 water, ions, and lipids coupled separately. The pressure was coupled
semi-isotropically using the Berendsen algorithm (47) andmaintained
at 1 bar with a compressibility of 5 × 10−6. The coupling constant
values for temperature and pressure were 1 and 4 ps, respectively.
The time step for integration was 20 fs, and particle coordinates were
written to the trajectory file every 200 ps.
Elastic network modelling was applied using a force constant of
1000 kJ mol−1 nm−2. The lower elastic bond cutoff used was 0.5 nm,
and the upper cutoff was 1.0 nm.
Simulations were produced using a protocol similar to that used
by Yamamoto et al. (48). The APCb domain was placed 10 nm away
from a preformed bilayer. The system was solvated with water. NaCl
ions (150 mM) were added. Energy minimization was performed forNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018300 steps before starting production runs of 1 ms, allowing the pro-
tein to diffuse in the box and encounter the membrane.
Lipids POPC, POPE, POPS, PIP2, andPIP3were used to formmem-
brane bilayers of the following compositions: 100%POPC; 100%POPE;
80% POPC and 20% POPS; 45% POPC, 45% POPE, and 10% POPS;
45% POPC, 42%POPE, 10%POPS, and 3%PIP2; and 45%POPC, 42%
POPE, 10%POPS, and 3%PIP3. Ensembles of 20 ms × 1 ms simulations
were set up for each bilayer type. The protein starting orientation was
sequentially rotated around the X, Y, and Z coordinates in each sim-
ulation of the ensemble to reduce bias.
Membrane-binding orientations of TgPLP1 APCb domain were
investigated by representing two-dimensional histograms of distance
between protein and membrane center of mass against the YY com-
ponent of the rotational matrix of APCb in membrane association
simulations. Rotation and translation in the x and y plane of the sim-
ulation were first removed, and then the rotational matrix required
for least-squares fitting of APCb onto a reference structure using
gmx rotmat was calculated. As the APCb domain was positioned at
a different orientation in each simulation, the rotational matrix was
calculated against a starting orientation of 0° on each of X, Y, and Z
matrix components for direct comparison of orientation.
Small-angle x-ray scattering
SAXS experimentswere carried out in 10mMtris (pH7.5) and 150mM
NaCl with deglycosylated TgPLP1 (residues 462 to 1072, MACPF and
APCb domain) at three different concentrations: 1.5, 5, and 8 mg/ml.
SAXS data were collected in BM29 at the ESRF with a momentum
transfer range of 0.004 Å−1 < q < 0.45 Å−1, where q = 4psin(q)/l
and 2q is the scattering angle. The scattering intensity from buffer
alone was subtracted from the averaged sample data to obtain the
protein scattering in solution. The radius of gyration (Rg) was calcu-
lated from a Guinier plot using AutoRg (49). The particle distance
distribution function P(r) was calculated in GNOM (50) using a low-
resolution data range (0.01 Å−1< q < 0.15 Å−1). Data reduction was
carried out using the ATSAS package (49).
The combination of theMACPF and APCbwas modeled into the
SAXS data using the online server MultiFoXS (http://modbase.
compbio.ucsf.edu/multifoxs/). Briefly, the disordered loops within
the MACPF domain and a polyhistidine tag at the C terminus of
the APCb domain were first modeled in MODELLER. Then, the
10 amino acid residues (residues 800 to 809), which were absent in
both structures, were treated as a flexible linker between the MACPF
domain and APCb domain acting as rigid bodies. In total, about
10,000 models were generated (51), and the SAXS profile was then
calculated for each conformation using the FoXS method (52). The
multistate models were enumerated in MultiFoXS using the branch-
and-bound method. To characterize the range of conformations
consistent with the SAXS data, we analyzed distributions of Rg for
the entire ensemble of 10,000models and the 1000 best-scoringN-state
models (N = 1… 5).
Molecular graphics
Molecular structures are displayed using PyMOL (The PyMOLMolec-
ular Graphics System, Version 2.0 Schrödinger, LLC), Chimera (53),
and VMD (54).
Liposome-binding assay
PIP3was prepared in chloroform/methanol (8:2), and other lipids were
dissolved in chloroform. Lipids (2 mg) with different compositionsTable 2. Data collection and refinement statistics for TgPLP1 APCb
domain.Native Pt derivativeData collectionSpace group C2 P1Cell dimensionsa, b, c (Å) 100.76, 50.21, 52.28 51.01, 52.88, 56.89a, b, g (°) 90, 90.96, 90 89.62, 63.34, 89.97Resolution (Å) 50.27–1.11 (1.15–1.11) 52.88–1.51 (1.55–1.51)Rmerge 0.065 (0.672) 0.038 (0.431)Rpim 0.031 (0.429) 0.018 (0.223)I/sI 11.4 (1.5) 30.5 (3.0)Completeness (%) 96.8 (76.3) 60.4 (3.7)Redundancy 6.1 (4.6) 8.6 (4.6)CC half 0.999 (0.568) 0.999 (0.845)RefinementResolution (Å) 50.37–1.11 (1.15–1.11)No. of reflections 605,707 (33,178)Unique reflections 99,521 (7,980)Rwork/Rfree 14.93/16.67No. of atomsProtein 2,039Ligand/ion 437B-factorsProtein 16.27Ligand/ion 33.93RMSDsBond lengths (Å) 0.006Bond angles (°) 1.089 of 12
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 were mixed and dried in a clean Pyrex tube at room temperature.
Residual chloroform was then removed in a desiccator attached
on a CARIO-SP diaphragm pump overnight. The lipid film was re-
hydrated by addition of 1 ml of solubilization buffer [20 mMHepes
(pH 7.5) and 150 mM NaCl] followed by vigorous vortexing. The
hydrated lipid film was then extruded through 100-nm pore mem-
branes 11 times. The quality of liposomes was checked by dynamic
light scattering, and they were used within 2 days. To perform lipo-
some sedimentation assays, 100 ml of liposomes at 2 mg/ml was
mixed with TgPLP1 MACPF-APCb or APCb for 2 hours at room
temperature. The liposome-protein mixture was then centrifuged at
67,000 rpm in an ultracentrifuge Optima TL with a TLA100.4 rotor
for 20 min. The resulting supernatant was removed, and liposome-
protein pellets were washed with 100 ml of solubilization buffer and
centrifuged again for 20 min at 67,000 rpm. The pellets were then dis-
solved in 10 ml of solubilization buffer with 5 ml of SDS-PAGE loading
buffer. Supernatant (10 ml) was loaded as well to check the unbound
protein in solution. The liposome sedimentation assay was performed
at least three times.
Negative-stain electron microscopy
TgPLP1 MACPF-APCb domain tandem or MACPF domain alone
preincubated with deoxycholate was placed on a C-flat carbon-
coated electron microscopy grid and stained using uranyl formate.
The samples were imaged using an FEI T12 electron microscope
operating at 120 kV.
GUV electroformation and imaging
The electroformationmethod was used for GUV preparation, basical-
ly as described in the study of Ruan et al. (25). The lipid mixture used
[POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine)/POPE
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine)/POPC
(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)/rhodamine-
DHPE (Lissamine rhodamine B 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt), 10:40:49.5:0.5 (mol/
mol)] and was dissolved in chloroform. The lipid mixture was spread
on the conductive site of an ITO slide, and dried under vacuum. Elec-
troformationwas carried out in sucrose solution [300mMsucrose and
1 mM Hepes (pH 7.4)] between two conductive ITO slides (Vesicle
Prep Pro, Nanion Technologies). The following electroformation pro-
tocol with ac current was applied: initial increase of amplitude from 0
to 3Vwith 5-Hz frequency, followed by 2 hours of constant amplitude
3 V and frequency 5 Hz, and ending with decreasing frequency from
5 to 0 Hz by constant amplitude 3 V. After electroformation, GUVs
were sedimented by addition of glucose solution [300 mM glucose,
1 mM Hepes (pH 7.4)] and outside buffer [10 mM Hepes, 150 mM
NaCl (pH 7.4)]. GUVs were left to sediment overnight. The osmolaritiy
of all solutions used forGUVpreparation and experimentswas adjusted
by using an osmometerOsmomat 3000 (GonotecGmbH).GUVswere
used immediately after sedimentation. To perform GUV-binding as-
says, GUVs were mixed with the TgPLP1 C-terminal APCb domain
(100 mg/ml final concentration). After incubation for 30 min at room
temperature in the dark, 0.5 mg of anti-His6 antibodies labeled with
Alexa Fluor 488 (Thermo Fisher Scientific) was added to the GUVs
and proteins. After an additional 30-min incubation at room tempera-
ture in the dark, images were recorded on a Leica TCS SP5 laser
scanning microscope with a 63× oil immersion objective (numerical
aperture, 1.4). The rhodamine-containing GUV membrane was ex-
cited at 543 nm, and emission was detected from 570 to 620 nm. AlexaNi et al., Sci. Adv. 2018;4 : eaaq0762 21 March 2018Fluor 488–labeled antibodies were excited at 488 nm, and emission
was detected from 510 to 530 nm. As a control, GUVs and antibodies
without protein were mixed and incubated for 60 min at room tem-
perature in the dark before imaging.
Planar lipid bilayer formation and recording
of conductances
For all experiments, planar lipid bilayers were formed from a mixture
of POPS/POPE/POPC= 1:4:5 (mol/mol/mol) dissolved in octanewith
a final concentration of lipids (5 mg/ml). For electrical measurements
in planar lipid bilayers, an integrated chip-based recording setupOrbit
mini and EDR2 software (Nanion Technologies) were used. Record-
ings were obtained in parallel with multielectrode-cavity-array chips
(Ionera Technologies). The aqueous phase was composed of 20 mM
Hepes and 500 mM NaCl (pH 7.4). Proteins were added to the cis
side of the bilayer to a final concentration of ~0.1mg/ml. To promote
pore insertion, a voltage of +150mVwith a 20-kHz sampling rate was
applied. All measurements were done at room temperature. Clampfit
(10.7.0.3.) was used to analyze current traces.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/3/eaaq0762/DC1
fig. S1. Domain architecture of ApiPLPs.
fig. S2. Structure of TgPLP1 MACPF domain in its helical assembly.
fig. S3. Analysis of the predicted conductance properties of TgPLP1 oligomers using the
program HOLE.
fig. S4. Analysis of the structural stability of TgPLP1 MACPF crystal structures during MD
simulation.
fig. S5. Comparison of TgPLP1 MACPF oligomeric crystal structures with atomistic simulations
showing changes in intersubunit hydrogen bonding.
fig. S6. Normalized bar charts showing main intersubunit hydrogen bonds during TgPLP1
MACPF helix and ring simulations.
fig. S7. Simulation and hydrogen bond analysis of representative ring and helix interfaces
isolated from oligomers to remove oligomeric constraints.
fig. S8. Details of TgPLP1 APCb domain crystal structure.
fig. S9. Details of coarse-grained and atomistic TgPLP1 APCb-membrane simulations.
fig. S10. AUC and SAXS study of TgPLP1 (MACPF-APCb).REFERENCES AND NOTES
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